Hepion Pharmaceuticals HEPA
OTC HEPA
$0.10 -0.04 (-28.57%)
At close: Nov 13, 2026 · 4:00 PM EST

Hepion Pharmaceuticals (HEPA) Return on Equity [ROE] (2014 - 2026)

Updated

Hepion Pharmaceuticals (HEPA) posted Return on Equity [ROE] of 187.04% for Q2 2026, up 540.61 percentage points from -353.57% a year earlier and up 49.96 percentage points from the prior quarter.

Analysis

Hepion Pharmaceuticals (HEPA) Return on Equity [ROE] (2014 - 2026) Analysis & Trends

For FY2025, Hepion Pharmaceuticals' Return on Equity [ROE] came in at -2064.14%, down 1576.83 percentage points from FY2024.

  • Annual Return on Equity [ROE] has declined for four consecutive years, with a five-year change of -1991.62 percentage points (FY2020 to FY2025).
  • In prior years, Hepion Pharmaceuticals' Return on Equity [ROE] was -487.31% in FY2024 (-316.05 pp), -171.26% in FY2023 (-112.18 pp), -59.08% in FY2022 (-10.07 pp) and -49.02% in FY2021 (+23.50 pp).
  • The Q2 2026 figure stands as the highest quarterly Return on Equity [ROE] in data going back to Q1 2018.
  • On a year-over-year basis, Return on Equity [ROE] increased in four of the last six quarters, with an average year-over-year change of +217.83 percentage points.
  • The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q1 2026, with a gain of 1758.83 percentage points; the weakest was Q1 2025, with a drop of 1101.70 percentage points.
  • According to Business Quant data, Return on Equity [ROE] for the three prior quarters was 137.08% (Q1 2026), -277.04% (Q4 2025) and -258.57% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Thermo Fisher Scientific 259.44 Bn 236.08 Bn 5.13 Bn 13.20%
2 Abbott Laboratories 187.98 Bn 162.45 Bn 7.39 Bn 9.09%
3 Danaher 163.91 Bn 143.58 Bn 3.84 Bn 8.15%
4 Intuitive Surgical 153.75 Bn 134.17 Bn 2.08 Bn 17.28%
5 Medtronic 131.67 Bn 97.80 Bn 6.34 Bn 17.46%
6 Stryker 117.84 Bn 104.03 Bn 4.25 Bn -4.01%
7 Boston Scientific 64.27 Bn 59.95 Bn 3.43 Bn 13.69%
8 Edwards Lifesciences 61.69 Bn 45.00 Bn 1.35 Bn 9.36%
9 Medline 51.94 Bn 49.07 Bn 1.93 Bn 4.56%
10 Hepion Pharmaceuticals 1.62 Mn -6.76 Mn - 187.04%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 187.04%
Mar 31, 2026 137.08%
Dec 31, 2025 -277.04%
Sep 30, 2025 -258.57%
Jun 30, 2025 -353.57%
Mar 31, 2025 -1,621.75%
Sep 30, 2024 -1,142.69%
Jun 30, 2024 -511.31%
Mar 31, 2024 -520.05%
Dec 31, 2023 -417.47%
Sep 30, 2023 -210.09%
Jun 30, 2023 -134.43%
Mar 31, 2023 -111.55%
Dec 31, 2022 -77.35%
Sep 30, 2022 -71.28%
Jun 30, 2022 -59.54%
Mar 31, 2022 -37.40%
Dec 31, 2021 -33.45%
Sep 30, 2021 -26.20%
Jun 30, 2021 -21.83%
API Access

Hepion Pharmaceuticals Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=HEPA&period=max&api_key=YOUR_API_KEY